| Watchers | 10,216 |
| 52-Wk Low | $5.80 |
| 52-Wk High | $20.96 |
| Market Cap | $1.64B |
| 52-Wk High | $20.96 |
| 52-Wk Low | $5.80 |
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Trillium Therapeutics Inc market cap is $1.64B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Trillium Therapeutics Inc 52 week high is $20.96 as of May 14, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Trillium Therapeutics Inc 52 week low is $5.80 as of May 14, 2024.
Trillium Therapeutics Inc stock price today is $18.45.
Trillium Therapeutics Inc stock price yesterday was $17.97.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Trillium Therapeutics Inc’s P/E ratio is 74.87.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Trillium Therapeutics Inc P/B ratio is 7.9220.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Trillium Therapeutics Inc 50-day moving average is $17.71.